Treatment of atopic dermatitis with 1% hydrocortisone and 25% pentane-1,5-diol: Effect on Staphylococcus aureus [10]

Acta Dermato-Venereologica

Volumn 86, Issue 4, 2006, Pages 372-373

  Falk, Mari Helen Sandström ^a   Särnhult, Tore ^a   Hedner, Thomas ^a   Faergemann, Jan ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

DICLOXACILLIN; FLUCLOXACILLIN; FUSIDIC ACID; HYDROCORTISONE; PENICILLIN G; PENTANE; PENTANE 1,5 DIOL; PSEUDOMONIC ACID; STEROID; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ATOPIC DERMATITIS; BACTERIAL COLONIZATION; BACTERICIDAL ACTIVITY; DRUG EFFECT; DRUG EFFICACY; EYE IRRITATION; HUMAN; LETTER; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PRIORITY JOURNAL; SKIN IRRITATION; STAPHYLOCOCCUS AUREUS; TREATMENT OUTCOME;

ADULT; ANTI-INFLAMMATORY AGENTS; DERMATITIS, ATOPIC; DOUBLE-BLIND METHOD; FEMALE; GLYCOLS; HUMANS; HYDROCORTISONE; MALE; OINTMENTS; SKIN; STAPHYLOCOCCUS AUREUS;

EID: 33746531705     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-0096     Document Type: Letter

References (13)

1. Williams HC. Epidemiology of atopic dermatitis. Clin Dermatol 2000; 25: 522-529.
2. Guzik TJ, Bzowska M, Kasprowicz A, Czerniawska-Mysik G, Wójcik K, Szmyd D, Adamek-Guzik T. Persistent skin colonization with Staphylococcus aureus in atopic dermatitis: relationship to clinical and immunological parameters. Clin Exp Allergy 2005; 35: 448-455.
3. Roll A, Cozzio A, Fischer B, Schmid-Grendelmeier P. Microbial colonization and atopic dermatitis. Cur Opin Allergy Clin Immunol 2004; 4: 373-378.
4. Rippke F, Schreiner V, Doering T, Maibach HI. Stratum corneum pH in atopic dermatitis: impact on skin barrier function and colonization with Staphylococcus aureus. Am J Clin Dermatol 2004; 5: 217-223.
5. Ong PY, Ohtake T, Brandt C, Strickland I, Boguniewicz M, Ganz T, et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Eng J Med 2002; 347: 1151-1160.
6. Bunikowski R, Mielke ME, Skarabis H, Worm M, Anagnostopoulos I, Kolde G, et al. Evidence for a disease-promoting effect of Staphylococcus aureus-derived exotoxins in atopic dermatitis. J Allergy Clin Immunol 2000; 105: 814-819.
7. Darsow U, Lübbe J, Taieb A, Seidenari S, Wollenberg A, Calza AM, et al. Position paper on diagnosis and treatment of atopic dermatitis. J Eur Dermatol Venereol 2005; 19: 286-295.
8. Peeters KABM, Mascini EM, Sanders CJG. Resistance of Staphylococcus aureus to fusidic acid. Int J Dermatol 2004; 43: 235-237.
9. Faergemann J, Hedner T, Larsson P. The in vitro activity of pentane-1,5-diol against aerobic bacteria. A new antimicrobial agent for topical usage? Acta Derm Venereol 2005; 85: 203-205.
10. Smyth HF, Carpenter CP, Weil CS, Pozzani UC, Striegel JA. Range findings toxicity data: List VI. Sam Ind Hyg Assoc J 1962; 23: 95-97.
11. Faergemann J, Fredriksson T. The antimycotic activity in vitro of five diols. Sabouraudia 1980; 18: 287-293.
12. Williams HC, Burney P, Pembroke A, Hay R. The UK Working party's diagnostic criteria for atopic dermatitis. III. Independent hospital validation. Br J Dermatol 1994; 131: 406-416.
13. Williamson P, Kligman AM. A new method for the quantitative investigation of cutaneous bacteria. J Invest Dermatol 1965; 45: 498-502.